Philips’ new biosensor automatically and continuously measures heart rate, respiratory rate, skin temperature, single-lead ECG, posture and activity data.
The data is sent to a computer running the Philips’ proprietary biosensor software, allowing clinicians to be regularly updated with every patient’s status. If a patient’s vital signs surpass a set limit, an alert can be issued by the software.
For physiotherapists, the prospect of a wireless biosensor that can detect posture and activity data presents an opportunity for mobilising very unwell patients. Fewer leads will make it easier to mobilise patients and monitor their activity.
What does Philips hope to achieve with its biosensor?
- Improve patient outcomes, reduced costs, and improved access to care.
- Help patients in low-acuity areas of the hospital to transition home.
- Detect early signs of patient deterioration and intervene early.
What are the potential benefits of this new technology? Are there any risks? Let us know in the comments section below.